CYRX Stock Overview
Provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Cryoport, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$6.41 |
| 52 Week High | US$20.11 |
| 52 Week Low | US$4.58 |
| Beta | 1.67 |
| 1 Month Change | -4.75% |
| 3 Month Change | -16.97% |
| 1 Year Change | -57.77% |
| 3 Year Change | -80.96% |
| 5 Year Change | -56.04% |
| Change since IPO | -94.23% |
Recent News & Updates
Recent updates
Cryoport, Inc. (NASDAQ:CYRX) Just Reported Earnings, And Analysts Cut Their Target Price
Mar 06
Market Cool On Cryoport, Inc.'s (NASDAQ:CYRX) Revenues Pushing Shares 25% Lower
Feb 22Investors Continue Waiting On Sidelines For Cryoport, Inc. (NASDAQ:CYRX)
Dec 03Is Cryoport (NASDAQ:CYRX) A Risky Investment?
Nov 06The Market Lifts Cryoport, Inc. (NASDAQ:CYRX) Shares 36% But It Can Do More
Aug 09Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?
Jul 22Slammed 28% Cryoport, Inc. (NASDAQ:CYRX) Screens Well Here But There Might Be A Catch
Jun 25Potential Upside For Cryoport, Inc. (NASDAQ:CYRX) Not Without Risk
Apr 15Cryoport, Inc. (NASDAQ:CYRX) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?
Mar 15Cryoport Tanks On Chilling Results And Bad Decisions
Mar 14Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?
Mar 10Fewer Investors Than Expected Jumping On Cryoport, Inc. (NASDAQ:CYRX)
Jan 15Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?
Oct 06Downgrade: Here's How Analysts See Cryoport, Inc. (NASDAQ:CYRX) Performing In The Near Term
Jul 23Cryoport, Inc.'s (NASDAQ:CYRX) Subdued P/S Might Signal An Opportunity
Jul 12Is Cryoport (NASDAQ:CYRX) A Risky Investment?
Jun 13Cryoport, Inc.'s (NASDAQ:CYRX) Intrinsic Value Is Potentially 96% Above Its Share Price
Mar 06Cryoport, Inc. (NASDAQ:CYRX) Analysts Just Cut Their EPS Forecasts Substantially
Nov 07Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?
Sep 23Cryoport: A Rare Investing Opportunity
Sep 22Cryoport enters into strategic relationship with Takeda's BioLife Plasma Services
Sep 08Cryoport: Rapid Growth Is Great, But Shares Look Overpriced
Jul 30Cryoport: To Resume Aggressive Growth
May 11Shareholder Returns
| CYRX | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | 2.9% | -2.2% | -2.2% |
| 1Y | -57.8% | -19.2% | 9.6% |
Return vs Industry: CYRX underperformed the US Life Sciences industry which returned -19.2% over the past year.
Return vs Market: CYRX underperformed the US Market which returned 9.6% over the past year.
Price Volatility
| CYRX volatility | |
|---|---|
| CYRX Average Weekly Movement | 19.3% |
| Life Sciences Industry Average Movement | 9.6% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 17.4% |
| 10% least volatile stocks in US Market | 3.4% |
Stable Share Price: CYRX's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: CYRX's weekly volatility has increased from 14% to 19% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 1,098 | Jerry Shelton | www.cryoportinc.com |
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport Express Cryogenic HV3 Shipping System (HV3); Smartpak II Condition Monitoring System and Tec4Med; Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as CRYOGENE, a biostorage solution for the provision of pre-clinical temperature-controlled biological materials management services; and Cryoport System Bioservices, such as controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release services.
Cryoport, Inc. Fundamentals Summary
| CYRX fundamental statistics | |
|---|---|
| Market cap | US$319.93m |
| Earnings (TTM) | -US$122.76m |
| Revenue (TTM) | US$228.39m |
1.4x
P/S Ratio-2.6x
P/E RatioIs CYRX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CYRX income statement (TTM) | |
|---|---|
| Revenue | US$228.39m |
| Cost of Revenue | US$128.75m |
| Gross Profit | US$99.63m |
| Other Expenses | US$222.39m |
| Earnings | -US$122.76m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.46 |
| Gross Margin | 43.62% |
| Net Profit Margin | -53.75% |
| Debt/Equity Ratio | 49.6% |
How did CYRX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/16 02:25 |
| End of Day Share Price | 2025/03/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cryoport, Inc. is covered by 16 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yuan Zhi | B. Riley Securities, Inc. |
| Andrew D'Silva | B. Riley Securities, Inc. |
| David Larsen | BTIG |